<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">6809844</article-id><article-id pub-id-type="doi">10.1093/ofid/ofz360.358</article-id><article-id pub-id-type="publisher-id">ofz360.358</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Poster Abstracts</subject></subj-group></subj-group></article-categories><title-group><article-title>283. Potentially Achievable Hepatitis A Vaccination Coverage with Simultaneous Administration of Vaccines Among Young Children in the United States</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Zhen</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Hill</surname><given-names>Holly</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Elam-Evans</surname><given-names>Laurie</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Michael</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Singleton</surname><given-names>James A</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0001"/></contrib></contrib-group><aff id="AF0001">
<institution>Centers for Disease Control and Prevention</institution>, Atlanta, Georgia</aff><pub-date pub-type="collection"><month>10</month><year>2019</year></pub-date><pub-date pub-type="epub" iso-8601-date="2019-10-23"><day>23</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>10</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>6</volume><issue>Suppl 2</issue><issue-title>IDWeek 2019 Abstracts</issue-title><fpage>S154</fpage><lpage>S155</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2019</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofz360.358.pdf"/><abstract><title>Abstract</title><sec id="s2"><title>Background</title><p>The Advisory Committee on Immunization Practices recommends simultaneous administration of all age-appropriate doses of vaccines. We estimated the vaccination coverage for &#x02265;2 doses of hepatitis A vaccine (&#x02265;2 HepA) that could have been achieved if opportunities for simultaneous administration with other recommended childhood vaccines had not been missed.</p></sec><sec id="s3"><title>Methods</title><p>We analyzed National Immunization Survey-Child data for 2008&#x02013;2017 in the United States. We defined potentially achievable &#x02265;2 HepA coverage by age 24 months as the possible coverage if opportunities for simultaneous administration with other age-appropriate doses of vaccines for children by age 24 months had not been missed. We compared potentially achievable vaccination coverage to reported &#x02265;2 HepA vaccination coverage by birth years 2007 to 2015. For children born in 2015, we stratified estimates by state and by selected socio-demographic factors. Both potentially achievable and reported &#x02265;2 HepA coverage were evaluated using a Kaplan&#x02013;Meier survival procedure to account for censoring of vaccination status.</p></sec><sec id="s4"><title>Results</title><p>Compared with reported vaccination coverage, potentially achievable coverage for &#x02265;2 HepA was at least 10 percentage points higher across birth years 2007 to 2015 and would have surpassed the 85% target of Healthy People 2020 for children born in 2015 (Figure 1). For the 2015 birth cohort, potentially achievable &#x02265;2 HepA coverage exceeded the 85% Healthy People 2020 target in ten states (Figure 2). In addition, potentially achievable vaccination coverage was higher than reported coverage across all selected socio-demographic factors, with differences ranging from 20.1 percentage-points (private insurance only) to 31.7 percentage-points (non-Hispanic Black) (Table 1).</p></sec><sec id="s5"><title>Conclusion</title><p>Potentially achievable coverage with &#x02265;2 HepA consistently exceeded reported coverage for children from nine recent birth cohorts and across all selected socio-demographic characteristics. Coverage could increase substantially if missed opportunities were eliminated. Evidence-based interventions such as establishment of standing orders, use of provider reminders, and use of immunization information systems are recommended to increase HepA coverage among young children.</p><p>
<graphic xlink:href="ofidis_ofz360_f0197.jpg" position="float" mimetype="image" orientation="portrait"/>
</p><p>
<graphic xlink:href="ofidis_ofz360_f0198.jpg" position="float" mimetype="image" orientation="portrait"/>
</p><p>
<graphic xlink:href="ofidis_ofz360_f0199.jpg" position="float" mimetype="image" orientation="portrait"/>
</p></sec><sec id="s6"><title>Disclosures</title><p>
<bold>All authors:</bold> No reported disclosures.</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front><back><notes id="n1"><p>
<bold>Session:</bold> 41. Hepatitis</p><p>
<italic>Thursday, October 3, 2019: 12:15 PM</italic>
</p></notes></back></article>